Compare Bank Tabungan Negara Persero Tbk (BBTN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Tabungan Negara Persero Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Tabungan Negara Persero Tbk trades at Rp1,220 (market cap 16.81T, 6.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bank Tabungan Negara Persero Tbk is far larger — about 102.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Tabungan Negara Persero Tbk is more actively traded (6.75M versus 187.4K). Which is the better fit depends on your goals.
| BBTN | OBAT | |
|---|---|---|
Market Cap | 16.81T | 164.65B |
Volume | 6.75M | 187.4K |
Lot | 67.48K | 1.87K |
Turnover | 8.19B | 44.35M |
Average Price | 1,213.4 | 236.67 |
Value | 8.19B | 44.35M |
Indicative Equilibrium Price | 1,220 | 242 |
Indicative Equilibrium Volume | 6.53K | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Tabungan Negara Persero Tbk
PT Bank Tabungan Negara (Persero) Tbk (the Bank) was originally established as a state-owned bank under the name Bank Tabungan Pos, dated February 9,1950. Subsequently, the name of the Bank was changed to Bank Tabungan Negara based on Government Regulation Amendment of Law No.4 of 1963. The Bank started operating as a state-owned commercial bank on April 29, 1989. The Bank started its activities based on sharia principles on February 14, 2005 through the establishment of its first sharia branch in Jakarta - Harmoni.
Read more on BBTN →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
